Evolution of mRNA-based vaccines: a regulator’s view

Vaccine Insights 2024; 3(3), 97–105

DOI: 10.18609/vac.2024.019

Published: 22 May
Ka-Wai Wan

Charlotte Barker, Commissioning Editor, Vaccine Insights, speaks with Ka-Wai Wan, Senior Pharmaceutical Assessor, Medicines and Healthcare products Regulatory Agency, about pandemic preparedness, the regulatory pathway for mRNA-based vaccines, and the opportunities and challenges posed by their rapid evolution.